Renal function

Ongoing clinical trials and approved products targeting Renal function, in radioligand therapy and PET/SPECT imaging. Data as of 26 October 2026.

0ongoing therapy trials

3ongoing imaging trials

0approved products

Target note

Full name: Renal function
Nature: Tracers filtered by the glomerulus or secreted by the tubules.
Normal expression: Kidneys, urinary tract.
Value: Measuring the filtration rate and the split function of each kidney.
Approaches: [99mTc]MAG3, DTPA, DMSA; [68Ga] chelates for PET.
Indications explored: Nephrology and urology, kidney dosimetry before radioligand therapy.
Points of caution: Hydration and bladder emptying to be standardised.

Ongoing imaging trials · 3Open in the radar →

Trial	Phase	Status	Sponsor	Countries
[99mTc]DTPANCT06359795 · Thyroid	No phase	Recruiting	Peking University Third Hospital	1
[99mTc]DTPANCT06116253 · Kidney	No phase	Active, not recruiting	NYU Langone Health	1
[99mTc]DTPANCT06973798 · Kidney	No phase	Not yet recruiting	Luo Yaping	1

Cite this page

Renal function. Theranostic Atlas, LaRadiopharmacie.fr. Data as of 26 October 2026. https://theranosticatlas.com/target/renal-function/ (accessed [date]).

A monitoring tool with no regulatory value: check every item at its source.